In vitro tests to predict in vivo performance of liposomal dosage forms
- 1 September 1993
- journal article
- review article
- Published by Elsevier in Chemistry and Physics of Lipids
- Vol. 64 (1-3) , 219-237
- https://doi.org/10.1016/0009-3084(93)90067-d
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Stability of liposomal doxorubicin formulations: Problems and prospectsMedicinal Research Reviews, 1993
- Prolongation of the Circulation Time of Doxorubicin Encapsulated in Liposomes Containing a Polyethylene Glycol-Derivatized Phospholipid: Pharmacokinetic Studies in Rodents and DogsPharmaceutical Research, 1993
- Preparation and Characterization of Liposomal Doxorubicin for Human UseJournal of Liposome Research, 1992
- Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycinBritish Journal of Cancer, 1991
- Optimization and Upscaling of Doxorubicin-Containing Liposomes for Clinical UseJournal of Pharmaceutical Sciences, 1990
- The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behaviorBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- Preclinical and Clinical Experience with a Doxorubicin-Liposome PreparationJournal of Liposome Research, 1990
- Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I studyEuropean Journal of Cancer and Clinical Oncology, 1989
- Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: Implications for pharmacokinetic studiesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1989
- Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour modelBritish Journal of Cancer, 1985